Response to "Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury".
Somers
Emily C
EC
Christman
Gregory M
GM
Fisseha
Senait
S
Marder
Wendy
W
McCune
W Joseph
WJ
D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists / Q000627:therapeutic use*; D006801:Humans; D010053:Ovary / Q000187:drug effects*; D016649:Primary Ovarian Insufficiency / Q000139:chemically induced* / Q000517:prevention & control; D020011:Protective Agents / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D020011:Protective Agents; D007987:Gonadotropin-Releasing Hormone